Medication Use in Multiple Sclerosis: A Population‐Based Comparison With the General Danish Population
Annals of Clinical and Translational Neurology · 2025-11 · 12 (11) · 2206-2213
DOI: 10.1002/acn3.70155 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 31.07.2025. Verfasst von Josefine Windfeld-Mathiasen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Multiple Sclerosis, Registries, Prescription Drugs. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Danish Multiple Sclerosis Society supports the management of the Danish Multiple Sclerosis Registry.
Abstract (Originalsprache)
Objective
To investigate the overall use of prescription medications among individuals with multiple sclerosis compared to the general population, with a focus on treatments beyond disease‐modifying therapies.
Methods
We conducted a nationwide, registry‐based study in Denmark. All residents with a diagnosis of multiple sclerosis aged 20–80 years and alive on January 1, 2023, were included and followed for 1 year. Each patient was matched with 10 individuals from the general population based on age, sex, and residence. Prescription data were obtained from the Danish National Prescription Registry and categorized using the Anatomical Therapeutic Chemical classification. Relative risks of medication use were calculated.
Results
A total of 14,491 individuals with multiple sclerosis and 144,910 matched controls were included. Patients with multiple sclerosis had significantly higher use of several therapeutic drug classes, including analgesics (51% vs. 33%; RR: 1.56, 95% CI: 1.52–1.60), agents for constipation (12% vs. 3%; RR: 4.61, 95% CI: 4.36–4.88), spasmolytics, and urological medications. Among specific drugs, the most pronounced differences were observed for modafinil (RR: 323.33, 95% CI: 228.67–457.19), baclofen (RR: 36.51, 95% CI: 33.33–39.99), and fesoterodine (RR: 36.36, 95% CI: 18.66–70.87). In contrast, individuals with multiple sclerosis had lower usage of antidiabetic medications and treatments for chronic obstructive pulmonary disease.
Interpretation
This large, population‐based study reveals extensive use of medications targeting symptoms and comorbidities in individuals with multiple sclerosis. These insights can guide healthcare providers in optimizing patient management, addressing overlooked treatment needs, and improving overall care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Neurology, The Danish Multiple Sclerosis Registry, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
- Department of Geriatric and Palliative Medicine, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
- Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
ORCID-Profile: Josefine Windfeld-Mathiasen, Ida M Heerfordt, Elisabeth Framke
Förderung
- The Danish Multiple Sclerosis Society supports the management of the Danish Multiple Sclerosis Registry
Zitieren
APA
Windfeld-Mathiasen, J., Horwitz, H., Heerfordt, I. M., Framke, E., & Magyari, M. (2025). Medication Use in Multiple Sclerosis: A Population‐Based Comparison With the General Danish Population. Annals of Clinical and Translational Neurology, 12(11), 2206-2213. https://doi.org/10.1002/acn3.70155
Vancouver
Windfeld-Mathiasen J, Horwitz H, Heerfordt IM, Framke E, Magyari M. Medication Use in Multiple Sclerosis: A Population‐Based Comparison With the General Danish Population. Annals of Clinical and Translational Neurology. 2025;12(11):2206-2213. doi:10.1002/acn3.70155
BibTeX
@article{WindfeldMathiasen2025,
author = {Windfeld-Mathiasen, Josefine and Horwitz, Henrik and Heerfordt, Ida M and Framke, Elisabeth and Magyari, Melinda},
title = {Medication Use in Multiple Sclerosis: A Population‐Based Comparison With the General Danish Population},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
volume = {12},
number = {11},
pages = {2206--2213},
doi = {10.1002/acn3.70155}
}
EUVIMED